Technical Description
The present invention relates to a nano-formulation of anticancer drug that exhibits a higher drug payload, low excipient amount, and releases drug in a sustained manner for efficient lung cancer management.
Problems Addressed
- High Cost
- Inefficient Existing Systems
- Rapid Drug Release
- Low Drug payloads
- Lacks Permeability
Tech Features
- Sustained Drug Release
- Effective Drug Payloads
- Higher Aqueous Solubility
- Improved Permeability
- High Flowability
- Excellent Aerosolization Performance
- Enhanced Tumor Penetration
- Lyophilized form
Target Audience
- Healthcare & Medical Sector
- Biomedical Engineering Industry
- Diagnostic Industry
- Pharmaceutical Industry
- Research & Development
Tech ID: P27-1546 TRL 4 Patent Status: Published Available For Exclusive and Non-exclusive License
